Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEGIN: ONCE SIMPLE USE
NCT01326026Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2011
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Mar 2011; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01326026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01326026.